Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-111284

Chief Financial Officer sold 9,869 shares at $48.26 ($476,278)

  • Chief Financial Officer gave 750 shares (gift)
  • Chief Financial Officer acquired 16,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Prasad Raju · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-14 Exercise or conversion : show line 1 in the form +10,000 16,767 D
2026-03-14 Exercise or conversion : show line 2 in the form +6,875 23,642 D
2026-03-16 Sale : show line 3 in the form −5,848 $48.26 $282,224 17,794 D
2026-03-16 Sale : show line 4 in the form −4,021 $48.26 $194,053 13,773 D
2026-03-16 Gift : show line 5 in the form −750 13,023 D
Open-market sales · 9,869 sh · avg $48.26 · $476,278

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-14 Exercise or conversion : show line 6 in the form Restricted Stock Units −10,000 10,000 D
2026-03-14 Exercise or conversion : show line 7 in the form Restricted Stock Units −6,875 20,625 D
Loading xslF345X05/ownership.xml…